Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Research
Rare EGFR mutation increases lung cancer risk more than smoking
In never-smokers, the risk for developing lung cancer increases by nearly 62 times when harboring the EGFR T790M mutation.
Marissa Russo
Sep 17, 2026 2:00pm
Pfizer’s first new ADC from Seagen buy fails ph. 3 NSCLC trial
Jun 23, 2026 7:15am
Obsidian leverages Galera reverse merger to go public
Apr 14, 2026 11:20am
Optellum tapped by NHS for AI-powered lung cancer diagnostic
Feb 2, 2026 8:55am
IceCure's treatment may extend survival in lung cancer patients
Nov 6, 2025 5:30am
Fierce Pharma
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm